Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
RO2-H82E3 | Human | Biotinylated Human ROR2 / NTRKR2 Protein, His,Avitag™ | ![]() |
![]() ![]() |
|
RO2-M5253 | Mouse | Mouse ROR2 / NTRKR2 Protein, Fc Tag | ![]() |
![]() ![]() |
|
RO2-H52E5 | Human | Human ROR2 / NTRKR2 Protein, His Tag | ![]() |
![]() ![]() |
|
RO2-H5251 | Human | Human ROR2 / NTRKR2 Protein, Fc Tag | ![]() |
![]() ![]() |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
CCT301-38 | CCT301-38; CCT301-38 AXL,CCT301 38; CCT301 38 AXL | Phase Ⅱ | BioAtla, F1 Oncology, Shanghai PerHum Therapeutics | Renal cell carcinoma | Details |
BA-3021 | CAB-ROR2-ADC; BA-3021; CAB-ADC; CAB-ROR2 | Phase Ⅱ | BioAtla | Triple negative breast cancer, Non small cell lung cancer (NSCLC), Solid tumours, Soft tissue sarcoma | Details |
This web search service is supported by Google Inc.